We invite postgraduate research proposals in a number of disease areas that impact significantly on patient care. We focus on exploring the mechanisms of disease, understanding the ways disease impacts patients’ lives, utilising new diagnostic and therapeutic techniques and developing new treatments.
As a student you will be registered with a University research institute, for many this is the Institute for Cellular Medicine (ICM). You will be supported in your studies through a structured programme of supervision and training via our Faculty of Medical Sciences Graduate School.
We undertake the following areas of research and offer MPhil, PhD and MD supervision in:
Newcastle hosts one of the most comprehensive organ transplant programmes in the world. This clinical expertise has developed in parallel with the applied immunobiology and transplantation research group. We are investigating aspects of the immunology of autoimmune diseases and cancer therapy, in addition to transplant rejection. We have themes to understand the interplay of the inflammatory and anti-inflammatory responses by a variety of pathways, and how these can be manipulated for therapeutic purposes. Further research theme focusses on primary immunodeficiency diseases.
There is strong emphasis on the integration of clinical investigation with basic science. Our research include:
We also research the effects of UVR on the skin including mitochondrial DNA damage as a UV biomarker.
This area emphasises on translational research, linking clinical- and laboratory-based science. Key research include:
Focus is on applied research and aims to underpin future clinical applications. Technology-oriented and demand-driven research is conducted which relates directly to health priority areas such as:
This research is sustained through extensive internal and external collaborations with leading UK and European academic and industrial groups, and has the ultimate goal of deploying next-generation diagnostic and therapeutic systems in the hospital and health-care environment.
There is a number of research programmes into the genetics, immunology and physiology of kidney disease and kidney transplantation. We maintain close links between basic scientists and clinicians with many translational programmes of work, from the laboratory to first-in-man and phase III clinical trials. Specific areas:
We have particular interests in:
Novel non-invasive methodologies using magnetic resonance are developed and applied to clinical research. Our research falls into two categories:
Our studies cover a broad range of topics (including diabetes, dementia, neuroscience, hepatology, cardiovascular, neuromuscular disease, metabolism, and respiratory research projects), but have a common theme of MR technical development and its application to clinical research.
We focus on connective tissue diseases in three, overlapping research programmes. These programmes aim to understand:
This research theme links with other local, national and international centres of excellence and has close integration of basic and clinical researchers and hosts the only immunotherapy centre in the UK.
Genetic approaches to the individualisation of drug therapy, including anticoagulants and anti-cancer drugs, and in the genetics of diverse non-Mendelian diseases, from diabetes to periodontal disease, are a focus. A wide range of knowledge and experience in both genetics and clinical sciences is utilised, with access to high-throughput genotyping platforms.
Our scientists and clinicians use in situ cellular technologies and large-scale gene expression profiling to study the normal and pathophysiological remodelling of vascular and uteroplacental tissues. Novel approaches to cellular interactions have been developed using a unique human tissue resource. Our research themes include:
We also have preclinical molecular biology projects in breast cancer research.
We conduct a broad range of research activities into acute and chronic lung diseases. As well as scientific studies into disease mechanisms, there is particular interest in translational medicine approaches to lung disease, studying human lung tissue and cells to explore potential for new treatments. Our current areas of research include:
Our research projects are concerned with the harmful effects of chemicals, including prescribed drugs, and finding ways to prevent and minimise these effects. We are attempting to measure the effects of fairly small amounts of chemicals, to provide ways of giving early warning of the start of harmful effects. We also study the adverse side-effects of medicines, including how conditions such as liver disease and heart disease can develop in people taking medicines for completely different medical conditions. Our current interests include: environmental chemicals and organophosphate pesticides, warfarin, psychiatric drugs and anti-cancer drugs.
Our new School of Pharmacy has scientists and clinicians working together on all aspects of pharmaceutical sciences and clinical pharmacy.
Our degrees in Genomic Medicine cover all aspects of genomic science and medicine, and will equip you with the knowledge and skills to be able to interpret and understand genomic data that increasingly impacts on service delivery to patients and the community.
The programme is aimed at students from a wide range of backgrounds, from basic scientists to all levels of healthcare professionals, and will provide a flexible, multi-disciplinary and multi-professional perspective in genomics, applied to clinical practice and medical research.
It is designed to equip you with the knowledge and skills to be able to interpret and understand genomic data that increasingly impacts on service delivery to patients and the community.
The training provided covers all aspects of genomic science and medicine (not merely DNA sequencing or detection of genetic variation), undertaken in one of the most cutting-edge scientific environments.
The course includes collaborations with:
The Institute of Cancer Research and Brunel University London may also co-supervise research projects.
This course is made up of three progressional levels (PG Cert, PG Dip and MSc), and you can apply to any level in the first instance. Read more about how this works under 'Choosing your course' in the admissions section.
One of the core modules available within the Master's degree (MSc) includes opportunities to access the emerging data from the 100,000 Genomes Project through the Genomics England Clinical Interpretation Partnership (GeCIP) training domains.
Hear from Genomic Medicine students and graduates on the National Heart and Lung Institute website.
A blended approach to learning is used, in both core and optional modules, combining face-to-face teaching and online distance learning. This is to provide flexibility for health professionals to combine their study with work.
Most modules will consist of one week of face-to-face teaching and up to three weeks of e-learning and independent study. The modules are offered on a cycle of 12 months, so that all modules become available once in each 12 month cycle.
The course is flexible and modular and is available as a full-time or part-time MSc delivered over one or two years respectively. There are also full-time and part-time Postgraduate Certificate (PG Cert) and Postgraduate Diploma (PG Dip) options.
In veterinary management of animals, anaesthesia (rendering animals unconscious to permit procedures) and analgesia (reducing the pain an animal is suffering) have vital importance in improving animal welfare, as well as permitting the ongoing developments in medical and surgical advances.
Knowledge and advances in anaesthesia over the last 20 years have been considerable. We can use techniques to block sensation locally or over a region of the body not just total unconsciousness. We have an array of drugs and methods of drug administration available to us in our fight against pain. Anaesthesia has always carried risks, and we have an increasing availability of monitoring equipment to help us monitor the physiological function of the body during anaesthesia with the aim of reducing morbidity and mortality in our animals.
The University of Edinburgh is offering this unique opportunity for an entirely online MSc to study these advances, during which students can gain knowledge and understanding in the equipment, drugs and techniques associated with anaesthesia and analgesia. Our team can provide a wide range of clinical and research experience across many species.
Our award-winning online learning technology is fully interactive and enables you to communicate with our highly qualified teaching staff from the comfort of your own home or workplace. Online students not only have access to Edinburgh’s excellent resources, but also become part of a supportive online community.
Expert tutors will support you through every stage of the programme and you can engage with fellow students in supportive and constructive online networks.
Your progress will be assessed through online presentations, essays, critical reviews of literature, student self- reflection activities, short-answer questions, scientific posters, group wiki events and peer review activities.
The programme is taught part time over 3 years, but its flexible nature will allow you a maximum of 6 years to complete it. There are also options for studying for a certificate (1-2 years) or a diploma (2-4 years).
Each year will consist of three 11-week terms, structured into two blocks of five weeks of study, with a week in between for independent study and reflection.
The Postgraduate Certificate year (Year 1) starts with a series of compulsory courses to give a foundation in veterinary anaesthesia and analgesia, then progresses to examine how this may be applied in a variety of species. In the Postgraduate Diploma year (Year 2), you have the choice of selected courses to tailor the programme to your requirements. A dissertation completes the final year, however, this is a very flexible course, which can be tailored to suit you (subject to approval).
You will also choose 2 out of 4 species-related courses in dogs and cats, equidae, ruminants, camelids and pigs or small mammals (e.g. rabbits, rats etc).
You will choose courses to total 60 credits from the following:
In addition, you could choose to select additional species courses from Year 1.
During the written reflective element of the programme you will have the opportunity to further develop your scientific skills and utilise scientific theory. The form of the dissertation may vary to suit individual candidates, subject to approval of a submitted proposal. The dissertation will be a piece of written work 10-15,000 words long, which may take the form of a research study, analysis of techniques used in previous clinical work or an extended literature review. A casebook or portfolio submission may also be permitted.
The MSc Veterinary Anaesthesia and Analgesia is likely to be desirable for veterinary surgeons seeking employment in research environments (e.g. as Named Veterinary Surgeon or other roles) due to the key importance of anaesthesia and the emphasis on this from Home Office regulation of research work in the UK.
The MSc will be a different route for progression for veterinary nurses who have key roles in private veterinary practices with regard to veterinary anaesthesia and analgesia. This may be desirable for practices wishing to show a wide range of expertise amongst their staff and patient support for surgical procedures.
The Centre for Inflammation Research (CIR) aims to promote the prevention, diagnosis and treatment of inflammatory diseases through interdisciplinary study of the initiation, regulation and resolution of inflammatory responses and provision of an outstanding environment for research training in the field.
CIR investigators aim to characterise and manipulate key control points in inflammation. We focus on:
We have particular interest in inflammatory diseases of the lung and kidney but the principles derived will have ready application to inflammatory responses in the liver, bowel, bone/joint and skin. There is also increasing development of research in the CIR into the links between inflammation and cancer.
The Centre was formally established in 1998.
Generic training in presentation skills, project management and writing skills is delivered through the University of Edinburgh's transferable skills programme.
The CIR is a multidisciplinary team of research groups under the directorship of Professor John Iredale. The CIR consists of more than 180 researchers, is equipped with state-of-the-art apparatus and is supported by external grant funding. The CIR is now located in the purpose-built Queen's Medical Research Institute along with the centres for Reproductive Biology and Cardiovascular Sciences.